Qube Research & Technologies LTD Stereotaxis, Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 94,745 shares of STXS stock, worth $209,386. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,745Holding current value
$209,386% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding STXS
# of Institutions
100Shares Held
42.8MCall Options Held
10.1KPut Options Held
11.2K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$30.2 Million11.38% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.71MShares$10.4 Million8.41% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$7.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$7.6 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$6.31 Million10.0% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $165M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...